#LiveRNA will advance mRNA-based immunotherapies for liver cancer, while #QrCiliopathies will drive new therapies for polycystic kidney disease.
@erc.europa.eu
#LiveRNA will advance mRNA-based immunotherapies for liver cancer, while #QrCiliopathies will drive new therapies for polycystic kidney disease.
@erc.europa.eu
Read more: www.hsr.it/news/2026/gi...
#PKDInternational #PKD #Research
Read more: www.hsr.it/news/2026/gi...
#PKDInternational #PKD #Research
Por Caroline Boletta de Oliveira Aguiar
aterraeredonda.com.br/estrategias-...
#aterraéredonda #CarolineBolettaDeOliveiraAguiar
Por Caroline Boletta de Oliveira Aguiar
aterraeredonda.com.br/estrategias-...
#aterraéredonda #CarolineBolettaDeOliveiraAguiar
youtu.be/MleCz8RQhNM
youtu.be/MleCz8RQhNM